NCT02891512

Very Low Frequency Magnetic Fields Versus the Supplement "Xinepa" in the Treatment of the Carpal Tunnel Syndrome

Effectiveness of Very Low Frequency Magnetic Fields Versus the Supplement "Xinepa" in the Treatment of the Carpal Tunnel Syndrome: Randomized Double-blind Controlled Clinical Trial.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 31 (actual)
• Sponsor: University of Roma La Sapienza · Academic / Other
• Sex: All
• Age: 20 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to determine the effectiveness of the treatment with very low frequency magnetic fields (ELF) on the reduction of pain and the relief of the associated signs such as sensitivity disorders that affect the first three fingers and half of the fourth finger of the hand in patients with carpal tunnel syndrome versus the supplement (= Xinepa).

Conditions

• Carpal Tunnel Syndrome

Interventions

Type	Name	Description
OTHER	ELF	Very low frequency magnetic fields (ELF) at intensity of 100 mT and a frequency of 1-80 Hz. Protocol (antiedema-antinflammatory): 12 sessions, 3 times a week for 4 consecutive weeks, each session lasted 30 minutes.
OTHER	Xinepa®	2 tablets of Xinepa daily (morning and evening) for 1 month.
OTHER	Placebo Xinepa®	2 tablets of Xinepa placebo daily (morning and evening) for 1 month.

Timeline

• Start date: 2015-07-01
• Primary completion: 2015-08-01
• Completion: 2016-01-01
• First posted: 2016-09-07
• Last updated: 2016-11-22

Locations

1 site across 1 country: Italy